Patients with advanced urothelial carcinoma had prolonged survival with Bavencio and BSC treatment, regardless of diabetes ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

Demographic disparities were observed in survival trends of patients with esophageal squamous cell carcinoma, with male sex and non-Hispanic Black race associated with increased risk of mortality. The ...

Roche’s freshly approved PI3K inhibitor Itovebi can help extend the lives of certain patients with breast cancer when used ... and clinically meaningful overall survival benefit compared with ...

Preliminary phase 1/1b dose expansion results of the bifunctional EGFR/TGFβ inhibitor ficerafusp alfa (BCA101) with pembrolizumab in patients with squamous cell carcinoma of the anal canal. This is an ...

A novel treatment approach combining neoadjuvant immunotherapy with chemoradiation showed promising results in patients with locally advanced esophageal squamous cell carcinoma (ESCC), according ...

Impact of combined resection of pancreas on long-term survival ... cancer. Preliminary results of the ALTER-E009 study: Efficacy and safety of anlotinib combined with radiotherapy in patients with ...

Lobectomy for stage 1A NSCLC offered the highest survival rates, with a five-year overall survival (OS ... includes a majority of lung cancer and esophageal cancer surgeries performed in the ...

Phase III CheckMate -8HW trial shows the combination of Opdivo (nivolumab) and Yervoy (ipilimumab) significantly improved progression-free survival and overall ... advanced or metastatic esophageal ...

“While the LEAP-015 trial did not show a statistically significant increase in overall survival, we were pleased to observe an improvement in progression-free survival and objective response rate.

The following is a summary of “Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal ... or absence (N0) of cancer spread to the lymph nodes, with no metastatic disease. The ...